Back to the main directory
Press Release
- Zai Lab Partner Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2 Trial of KarXT in Schizophrenia by GlobeNewsWire
- CinCor Reports Second Quarter Financial Results and Provides Corporate Update by GlobeNewsWire
- 1-800-FLOWERS.COM, Inc. to Release Results for its Fiscal 2022 Fourth Quarter and Full Year on Thursday, September 1, 2022 by BusinessWire
- Adamis Pharmaceuticals Schedules Second Quarter 2022 Financial Results Conference Call and Corporate Update by GlobeNewsWire
- MariMed Acquires Fifth Adult-Use Dispensary License in Illinois by GlobeNewsWire
- Inspirato Announces Strong Second Quarter 2022 Results, Reiterates Full Year 2022 Guidance by GlobeNewsWire
- Indberetning af ledende medarbejderes og disses nærtståendes transaktioner med A.P. Møller - Mærsk A/S aktier i forbindelse med aktietilbagekøbsprogram. by GlobeNewsWire
- Juggernaut Intersects Two Mineralized Zones in First 2022 Step-Out Drill Hole 120 Meters Along Strike and 90 Meters Down-Dip On Goldilocks Discovery by GlobeNewsWire
- DGAP-News: Bilfinger SE: Share Buyback by EQS Group AG
- Stack Capital Announces Exit From the TSX Sandbox Program by GlobeNewsWire
- Iris Energy Doubles Operating Capacity to >2.3 EH/s by GlobeNewsWire
- Pyxis Tankers Announces Record Financial Results for the Three Months Ended June 30, 2022 by GlobeNewsWire
- Marel: Transactions in relation to a share buyback program by GlobeNewsWire
- Plexus Corp. Opens New Manufacturing Facility in Bangkok, Thailand by GlobeNewsWire
- Lincoln Educational Services Reports Second Quarter 2022 Results by GlobeNewsWire
- Bombardier annonce une commande ferme pour le premier avion d’affaires Challenger 3500 en Europe pour du nolisement par Air Corporate S.R.L. by GlobeNewsWire
- Indaptus Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update by GlobeNewsWire
- Impel Pharmaceuticals to Report Second Quarter 2022 Financial Results on Monday, August 15, 2022 by GlobeNewsWire
- RespireRx Pharmaceuticals Inc. Announces that Sleep Review has discussed the RespireRx Dronabinol Obstructive Sleep Apnea (OSA) Program in its June 13, 2022 Edition by GlobeNewsWire
- TRACON Pharmaceuticals Announces Submission of IND Application for CTLA-4 Antibody YH001 for the Treatment of Front-line Sarcoma Patients in Combination with Envafolimab by GlobeNewsWire
- Vaxart Appoints W. Mark Watson to its Board of Directors by GlobeNewsWire
- Novo Completes Second and Final Tranche of Sale of New Found Gold Shares for C$57.0 Million by GlobeNewsWire
- BlueLinx to Participate in Jefferies Industrials Conference by GlobeNewsWire
- VERB’S MARKET Vendors Share Their Experience On Shopfest – The Nation’s Biggest Livestream Shopping Event To Date by GlobeNewsWire
- Fluence Energy, Inc. Announces Third Quarter Earnings Release Date, Conference Call and Webcast by GlobeNewsWire